Improvement of assurance including security for wireless sensor networks using dispersed data transmission

AbstractAssurance networks are one of the essential technologies of New-generation Networks. Assurance is defined as the capability of guaranteeing functional and non-functional system properties such as dependability, security, timeliness and adaptability to heterogeneous and changing requirements. Assurance is essential for sustainable networks and this research focused specifically on providing assurance for WSNs. Node capture attacks are one prospective kind of attack on WSNs. To reduce negative effect of node capture attacks, we have previously proposed secure decentralized data transfer. In this proposed method, it was assumed that multiple paths were in place. In this paper as well, we again propose using the multipath routing method. To make multiple paths fit our previously proposed method, we have modified ATR (Augmented Tree Based Routing). We have conducted simulation experiments using our proposed method in a network simulator. The results show that our previously proposed method is effective in both cases in which the network size is small or large. In addition, we conducted other simulation experiments to measure several aspects of the assurance of our method. We measured in terms of varying parameters such as node densities, distance between the source and the destination nodes, and so on. Additionally, our method is more assured than the single path-based method

Carrier filtering effect for enhanced thermopower in a body-centered tetragonal ruthenate

Charged carriers in solids diffuse from hot to cold sides under temperature gradient to induce the thermoelectric voltage. Carrier filtering effect, which only passes either electrons or holes for the conduction process, is an efficient method to enhance such voltage, although it is challenging to experimentally realize it especially in conventional metals with weak energy dependence of the density of states near the Fermi level. Here we measure the in-plane and out-of-plane thermopower of the layered perovskite Sr$_2$RuO$_4$ single crystals above room temperature, and find that the out-of-plane thermopower is largely enhanced with increasing temperature, while the in-plane one seems to remain a temperature-independent constant value which is expected from the Heikes formula. The observed large out-of-plane thermopower may originate from the recently proposed intriguing hole filtering effect in the body-centered tetragonal system, in which the carrier hopping through the centered atom is essential. Thus, the present carrier filtering effect may be a universal property to be applicable in various materials belonging to such crystal system.Comment: 6 pages, 4 figure

Indication for mild therapeutic hypothermia based on an initial Glasgow Coma Scale motor score

Although neurological evaluation using the Glasgow Coma Scale motor score is mandatory for post-cardiac arrest patients, further study is required to determine if this score can be used as an indicator for mild therapeutic hypothermia. Although the current study conducted by Natsukawa et al. presents interesting data, there are some critical issues regarding study design, selection bias, and interpretation of study results that should be pointed out

Resolvin E1 Inhibits Osteoclastogenesis and Bone Resorption by Suppressing IL-17-induced RANKL Expression in Osteoblasts and RANKL-induced Osteoclast Differentiation

【Background】 Resolvin E1 (RvE1) derived from the ω-3 polyunsaturated fatty acid eicosapentaenoic acid is known to be a potent pro-resolving lipid mediator that prevents chronic inflammation and osteoclastogenesis. We investigated the inhibitory effects of RvE1 on osteoclastogenesis and bone resorption to clarify its therapeutic potential for rheumatoid arthritis (RA). 【Methods】 Receptor activator of nuclear factor-κB ligand (RANKL)-induced osteoclast differentiation was assessed with tartrate-resistant acid phosphatase staining. RANKL-induced bone resorption was assessed by the measurement of pit formation using calcium phosphate-labeled fluorescent polyanionic molecules in RAW264.7 cells as osteoclast precursors. The effects of RvE1 on the RANKL-induced mRNA expression of osteoclast-specific genes and transcriptional factors such as c-fos and nuclear factor of activated T cells c1 (NFATc1) in RAW264.7 cells were measured by quantitative real-time PCR. The distribution of NFATc1 induced by RANKL was evaluated by immunofluorescence staining in RAW264.7 cells. To analyze the mechanism of the inhibitory effect of RvE1 on osteoclastogenesis, we measured IL-17-induced RANKL mRNA expression in MC3T3-E1 osteoblast cells treated with RvE1 using quantitative real-time PCR and determined the level of prostaglandin E2 (PGE2) production by enzyme-linked immunosorbent assay. 【Results】 RvE1 significantly suppressed RANKL-induced osteoclast differentiation and bone resorption. RvE1 inhibited the RANKL-induced mRNA expression of osteoclast-specific genes along with the transcription factors NFATc1 and c-fos. Moreover, NFATc1 translocation from the cytoplasm to the nucleus of RAW264.7 cells was suppressed following RvE1 treatment. RvE1 also inhibited IL-17-induced RANKL mRNA expression and PGE2 production in MC3T3-E1 cells. 【Conclusion】 RvE1 inhibited osteoclastogenesis and bone resorption by suppressing RANKL-induced NFATc1 and c-fos expression in osteoclasts and IL-17-induced RANKL expression through the autocrine action of PGE2 in osteoblasts. Our data suggest RvE1 as a new therapeutic target of RA

Neutrophils and Asthma

Although eosinophilic inflammation is characteristic of asthma pathogenesis, neutrophilic inflammation is also marked, and eosinophils and neutrophils can coexist in some cases. Based on the proportion of sputum cell differentiation, asthma is classified into eosinophilic asthma, neutrophilic asthma, neutrophilic and eosinophilic asthma, and paucigranulocytic asthma. Classification by bronchoalveolar lavage is also performed. Eosinophilic asthma accounts for most severe asthma cases, but neutrophilic asthma or a mixture of the two types can also present a severe phenotype. Biomarkers for the diagnosis of neutrophilic asthma include sputum neutrophils, blood neutrophils, chitinase-3-like protein, and hydrogen sulfide in sputum and serum. Thymic stromal lymphoprotein (TSLP)/T-helper 17 pathways, bacterial colonization/microbiome, neutrophil extracellular traps, and activation of nucleotide-binding oligomerization domain-like receptor family, pyrin domain-containing 3 pathways are involved in the pathophysiology of neutrophilic asthma and coexistence of obesity, gastroesophageal reflux disease, and habitual cigarette smoking have been associated with its pathogenesis. Thus, targeting neutrophilic asthma is important. Smoking cessation, neutrophil-targeting treatments, and biologics have been tested as treatments for severe asthma, but most clinical studies have not focused on neutrophilic asthma. Phosphodiesterase inhibitors, anti-TSLP antibodies, azithromycin, and anti-cholinergic agents are promising drugs for neutrophilic asthma. However, clinical research targeting neutrophilic inflammation is required to elucidate the optimal treatment